Central Admixture Pharmacy Services Recalls Neonate D5 Bridge IV Infusion Bags
Central Admixture Pharmacy Services is recalling two bags of a neonatal IV infusion bag due to out-of-specification sterility test results.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which per the rubric mandates a severity score of 5 (Critical).
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling two bags of Rose Medical Center (CO) Neonate D5 Bridge, Trophamine 3% Dextrose 5%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 350 ml, sterile injectable, Rx only, compounded drug, IV infusion bags. The recall is due to out-of-specification results for the sterility test for microbial contamination.
The affected product is identified by lot number 37-74755, made on 15 DEC 2014, with an expiration date of 24 DEC 2014. The CAPS Rx number is 37-74755-0-2-R, and the Disp ID is 37-1124670. The product was distributed nationwide.
Consumers and healthcare providers should stop using the affected product and contact Central Admixture Pharmacy Services, Inc. for further instructions.
The recalled product
- Product
- Rose Medical Center (CO) Neonate D5 Bridge, Trophamine 3% Dextrose 5%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 350 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS…
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Compounded IV Infusion
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- lot number 37-74755
- Made on 15 DEC 2014
- EXP 24 DEC 2014
- CAPS Rx: 37-74755-0-2-R
- Disp ID: 37-1124670.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 34 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 34 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighEphedrine Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighFentanyl injectable syringes recalled nationwide for sterility assurance failure
FDA (Drugs) · 2023-10-11
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- HighNeonatal TPN IV Bags Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-09-06
- HighNeonatal IV Nutrition Bags Recalled Due to Sterility Assurance Failures
FDA (Drugs) · 2023-08-09
- HighFDA Recalls Neonatal TPN Starter Bag for Lacking Sterility Assurance
FDA (Drugs) · 2023-08-09
- HighNeonatal TPN Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-08-09
- HighHeparin intravenous bags recalled due to sterility assurance failure
FDA (Drugs) · 2023-08-09
- HighNeonatal TPN Starter Bags Recalled for Unassured Sterility
FDA (Drugs) · 2023-05-31